The move wouldn't legalize marijuana, but moving it from Schedule I to Schedule III would allow the FDA to study it for medical purposes
The first grant program financed with tax revenue from legal cannabis sales has opened in New York
Two compounds significantly improved metabolic health and liver function in those with common disease